
Ask ten peptide suppliers where their product is made and eight will tell you "our own factory." Ask for a photo of the reactor, the name of the site, or the lot number of the last batch that shipped, and the conversation tends to go quiet.
That gap between the word factory and the thing itself is where most sourcing problems begin. This guide is for the people on the buying side — brand owners, formulators, distributors, lab managers — who need a peptide factory they can still hold accountable six months after the first order, not just a catalogue and a fast reply on WhatsApp.
There are three layers in the peptide supply chain, and online they all get flattened into one word.
At the bottom are the raw material suppliers: protected amino acids, resins, reagents. In the middle sit the actual synthesis sites — solid-phase peptide synthesis (SPPS) lines with reactors, purification skids and analytical labs. On top are the trading and export houses, which buy from the middle layer, relabel, mark up, and present themselves as manufacturers.
None of this is illegal. A good trader is genuinely useful: they handle export paperwork, consolidate orders, and know the market better than most factories do. The problem is thinking you're buying from layer two when you're actually buying from layer three. Then a batch fails, or a customer asks a technical question, and nobody upstream will pick up the phone.
If your product depends on batch-to-batch consistency, you want a line of sight to the reactor. That's the entire point of sourcing from a peptide factory instead of a marketplace listing.
Purity is the number everyone asks about, and it's also the easiest number to manipulate. What actually determines what arrives in the vial:
1. The synthesis route, and the scale it runs at. Short sequences are forgiving. Difficult ones — the sequences with hydrophobic stretches, or the ones that aggregate on the resin — expose whether a site has real process knowledge or just a recipe. Ask how they handle a sequence that comes off the resin at 70% crude purity. If the answer is "we run it again," that purification cost has to land somewhere, either in their margin or in your quote.
2. Purification, and how many passes you're paying for. Preparative HPLC is where the skill and the money sit. Two passes and three passes give you noticeably different impurity profiles, even when both are reported at the same purity. The honest version of this conversation includes a chromatogram, not just a headline percentage.
3. In-house analytics. A site with its own QC lab runs HPLC, mass spectrometry, water content and often residual solvent and counter-ion checks on every batch. A site without one is outsourcing its own quality control, which means it can't release product on its own authority — and can't investigate a complaint properly either.
4. Documentation discipline. Batch numbers that trace back to a retained sample. Deviation records for out-of-spec material. Stability data taken at real intervals, not extrapolated. Change control when a raw material supplier switches. This is the least glamorous part of running a peptide factory, and the one that decides whether a recall is a bad week or a bad year.
A COA is a document, and documents get recycled. A real one carries:
A single-page PDF with a company logo and "Purity: 99.2%" is decoration. It tells you what someone typed, not what came off the column.
Two things worth requesting that most buyers never ask for:
The raw instrument export. Not a screenshot, not a re-drawn curve — the PDF that comes out of the HPLC or MS software, carrying the software's own header. Re-drawn chromatograms are a classic tell.
The same batch number in three places. Label, COA, invoice. If they don't match, stop and ask why before money moves.
We once received two COAs from the same vendor, both labelled with the same batch, each claiming better than 98% purity — with different retention times, different peak shapes and different file timestamps. The batch existed. The analysis didn't.
Most buyers never see the site. That's fine. You can still verify a lot from a desk.
Ask for a live walkthrough, not a gallery. Five minutes on a video call, phone walking through the synthesis area, opening the freezer, showing the logbook and the balance reading — that's hard to fake. A folder of stock photos is easy.
Buy a sample and re-test it independently. Send a blind sample to an analytical lab in your own market and compare their numbers with the COA that came in the box. This one step filters out more suppliers than everything else on this list combined.
Cross-check the paper trail. The name and address on the business registration, the invoice header and the shipping documents should tell one consistent story. If the registered scope of business doesn't mention manufacturing, that's worth asking about directly.
Ask for a reference your own size. Not a logo wall. A customer ordering at roughly your volume who will talk to you for ten minutes.
Ask what a certification actually covers. "ISO 9001" and "GMP" get thrown around loosely. Ask which legal entity holds the certificate and what the scope statement says. In plenty of markets, the specific filings the end product needs matter more than the framed certificate in reception — and a factory that says it can supply "whatever you need" for a regulated market is usually telling you it hasn't done it yet.
Small sites and large sites solve different problems.
A smaller facility usually runs flexible minimum order quantities, turns around unusual sequences faster, and will let you talk to the person who actually ran the reaction. A larger site gives you better unit economics at volume, tighter consistency across big batches, and heavier documentation — but a longer queue and less appetite for a 50 mg pilot.
The mistake I see most often is choosing on unit price at the sample stage. The price at 10 mg tells you very little about what you'll pay at 10 kg, or whether the process transfers cleanly when you scale. Ask instead:
Every peptide quote is a bundle: raw material grade, number of purification passes, depth of testing, packaging, documentation, and regulatory overhead. When a quote comes in noticeably lower than the rest, one or more of those has been trimmed. Sometimes that's a fair trade for an early research project. It gets expensive when the item that got trimmed was the testing.
A facility that synthesises peptides — usually by solid-phase synthesis — then purifies, analyses and packages them for supply. It's different from a trading company, which resells product made somewhere else.
Ask for the synthesis site, a live walkthrough, a batch traceable from label to COA to invoice, and an independent re-test of a sample. A genuine manufacturer answers all four without friction.
Purity is method-dependent, so the figure only means something next to the method and the chromatogram. Batch-to-batch consistency matters more than the headline number — and so does whether the site will re-test a retained sample from your lot.
Often yes, though minimum order size and tooling lead time vary a lot between sites. Ask for the transfer plan and how many batches a new sequence typically takes to settle.
Not automatically. Cutting out a trading layer usually reduces cost, but it also removes the export and consolidation work a trader does. Compare total landed cost and support, not the headline figure.
If you're mid-way through supplier selection, the useful move is small and boring. Take your shortlist of two or three, send each the same blind sample, and ask each for a live walkthrough plus a lot-to-invoice trace. The answers will sort themselves out faster than any amount of catalogue reading.
Navigation
Send Us A Message
Specialized field of steel wire ropes
24/7 before-sales and after-sales services
Comprehensive technical support